Brugada Syndrome
AHA: Risk reduction, appropriate action critical with drug-induced arrhythmias
Several drugs may exacerbate or cause arrhythmias, but risk reduction, drug discontinuation and treatment when appropriate may help prevent these conditions, according to a scientific statement from the American Heart Association.
An Interesting Case An Evanescent ECG Pattern
This is an interesting case that presented to one of Atrium Health’s emergency departments.
Part of the Healio Network
Brugada Criteria
The Brugada Criteria are commonly used to determine whether a wide complex tachycardia is from ventricular tachycardia or supraventricular tachycardia with aberrancy.
Part of the Healio Network
Brugada Syndrome ECG Review
Brugada Syndrome is a genetic disorder that results in sudden cardiac death from polymorphic ventricular tachycardia or ventricular fibrillation in the setting of a structurally normal heart.
Part of the Healio Network
Ajmaline
Ajmaline is a class IA antiarrhythmic drug used diagnostically (not used therapeutically) to elicit ECG changes in patients suspected to have Brugada syndrome.
Part of the Healio Network
Bidirectional Ventricular Tachycardia
Bidirectional ventricular tachycardia occurs when the QRS axis alternates with every other beat. This is a pathognomonic rhythm during digoxin toxicity, however is relatively rare.